Maple-Brown Abbott deal presents complementary growth path for Antipodes

Maple-Brown Abbott Antipodes partners antipodes M&A Pinnacle Investment Management

2 August 2024
| By Laura Dew |
image
image image
expand image

The acquisition of Maple-Brown Abbott (MBA) is expected to be earnings accretive for Antipodes Partners and presents it with further avenues for growth.

It was announced in mid-July that fund manager MBA had finalised an agreement to be acquired by Antipodes Partners, an affiliate of Pinnacle Investment Management.

The size of the deal was not disclosed, but the combined firm will have $18.6 billion in assets under management, almost equally divided between the two firms.

Antipodes was founded in 2015 and manages global and emerging market equities, while MBA was established back in 1984, specialising in Australian equities as well Asia-Pacific equities and multi-asset.

On a call announcing the firm’s full-year results, Pinnacle managing director Ian Macoun was asked how the acquisition was expected to benefit Antipodes.

“Maple-Brown Abbott is accretive to Antipodes, they have put capital into that and Pinnacle has put in its pro-rata share of the capital requirement. That will be very nicely accretive.”

Dan Longan, Pinnacle chief financial officer, added: “We think it’s a deal that makes a lot of sense for Antipodes and we absolutely understand the rationale there. We think it gives them further avenues for future growth in asset classes that are pretty nicely complementary.

“But it will take them a bit of time to do the things they need to do to bring those businesses together before we see real significant earnings growth on top of that modest earnings accretion.” 

During the financial year, Antipodes also acquired three Asia-focused retail funds which expanded its product suite. The firm now represents 8.5 per cent of Pinnacle’s total funds under management, making it Pinnacle’s fifth-largest affiliate out of 15.

If the MBA deal proceeds, MBA’s global listed infrastructure, Australian value equities, and Australian small companies investment teams will operate autonomously under the MBA brand, alongside Antipodes’ existing global equities investment team.

MBA’s global listed infrastructure investment capability will continue to be majority-owned by its investment team led by Andrew Maple-Brown, Steven Kempler and Justin Lannen, and managed as a discrete entity.

There will be no changes to personnel within the MBA Australian value equities and MBA Australian small companies teams, which will report to Andrew Findlay, Antipodes’ managing director and CEO.
 

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

3 weeks 4 days ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month ago

Insignia Financial has confirmed it is considering a preliminary non-binding proposal received from a US private equity giant to acquire the firm. ...

1 week 2 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

5 days ago

Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equi...

4 days 4 hours ago